First episode [tmco]
Schizophrenia [mobd]
Patients [podg]
early stages [tmco]
Illness [fndg]
Antipsychotic [phsu]
treatment [ftcn]
Objective [inpr]
Well [qlco]
Established [qlco]
Schizophrenia [mobd]
Patients [podg]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
risk factors [qnco]
early stages [tmco]
Schizophrenia [mobd]
Illness [fndg]
Antipsychotics [phsu]
treatment [ftcn]
Clear [qlco]
Study [mnob]
METABOLIC FEATURES [clna]
Patients [podg]
Methods [inpr]
Performed [ftcn]
Retrospective Cohort Study [resa]
setting [ftcn]
included [ftcn]
Antipsychotic [phsu]
First episode [tmco]
Schizophrenia [mobd]
First episode [tmco]
Schizophrenia [mobd]
Inpatients [podg]
baseline [bodm]
Metabolic [ftcn]
measurements [ftcn]
Following [tmco]
Short-term [tmco]
treatment [ftcn]
Antipsychotic Drugs [phsu]
Hypertriglyceridaemia [fndg]
Hypercholesterolaemia [dsyn]
Hyperglycaemia [dsyn]
Patients [podg]
First episode [tmco]
Schizophrenia [mobd]
General Population [popg]
Patients [podg]
First episode [tmco]
Schizophrenia [mobd]
General Population [popg]
Profiles, Metabolic [npop]
Lipid [lipd]
Abnormalities [cgab]
Insulin Resistance [patf]
Fasting [fndg]
Glucose [bacs, carb, phsu]
Decreased [qnco]
Short-term [tmco]
days [tmco]
Antipsychotics [phsu]
Exposure NOS [inpo]
Compared [acty]
baseline [bodm]
Metabolic Profile [npop]
Polypharmacy [fndg]
Indicated [fndg]
Early-onset [fndg]
Nature [idcn]
Abnormalities [cgab]
Drug [phsu]
First episode [tmco]
Schizophrenia [mobd]
Patients [podg]
lipids metabolism [moft]
Antipsychotic [phsu]
Exposure NOS [inpo]
Monitoring [hlca]
Required [ftcn]
Purpose [ftcn]
Early Detection [diap]
Prevention [topp]
Initial [tmco]
Metabolic [ftcn]
???lead [elii, hops]
Diabetes Mellitus [dsyn]
Cardiovascular disease [dsyn]
Reserve [acty]
